pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·3h ago·1 min read
save

Trump-era health funding cuts reshape U.S. health system, prompting Medicaid coverage changes

Aug 25, 2026·read at STAT ↗RegulatoryNeutral

STAT’s D.C. Diagnosis newsletter examines how recent Republican health‑care funding cuts are altering the nation’s health‑care safety net. The series, led by Washington correspondent John Wilkerson, highlights the scale of the cuts and their ripple effects across hospitals and public programs.

One focus is Medicaid, which is testing a new approach that could limit drug coverage for beneficiaries. The article suggests this shift may increase barriers for patients needing expensive therapies.

The piece also notes broader cultural trends, such as a controversial suggestion from an RFK Jr. adviser that people rely on AI rather than doctors for medical advice. Overall, the analysis underscores how political decisions are reshaping health‑care delivery and financing.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: How Trump’s funding cuts are reshaping the health system”

read at STAT ↗
405 words · retrieved 3h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Moderna, Inc.
topics
OncologymRNA Therapeutic

related stories

  • 4h agoCellares cuts jobs after losing pharma customerBioSpace
  • Aug 6Third time’s the charm for Replimune as melanoma drug earns FDA greenlightBioSpace
  • Aug 6STAT+: FDA approves Replimune melanoma drug previously rejected twiceSTAT
  • Aug 6Chutes & Ladders—BioNTech brings in Sobi CEOFierce Biotech
  • Aug 6Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he wasSTAT